Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Novartis - BeiGene's Tislelizumab Aces Late-Stage Esophageal Cancer Trial

Novartis Chemotherapy Cancer BGNE EMA NVS European Medicines Agency FDA Nasdaq Novartis AG
  • Novartis AG (NYSE:NVS) has announced topline results from an interim analysis of the Phase 3 RATIONALE 306 study of tislelizumab plus chemotherapy in esophageal squamous cell carcinoma (ESCC).
  • Data showed that tislelizumab plus chemotherapy significantly improved overall survival (OS) compared to chemotherapy in patients with previously untreated unresectable, locally advanced, recurrent, or metastatic ESCC, regardless of PD-L1 expression. 
  • Novartis intends to submit these data to regulatory authorities and collaborate with BeiGene Ltd (NASDAQ:BGNE) to present them at an upcoming medical meeting.
  • Tislelizumab is currently under review by the FDA and the European Medicines Agency (EMA) for advanced or metastatic ESCC after prior chemotherapy. 
  • The EMA is also reviewing tislelizumab for advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy and in combination with chemotherapy for previously untreated advanced or metastatic NSCLC.
  • Price Action: NVS shares are up 0.03% at $88.99, and BGNE shares are up 6.42% at $162.37 during the market session on the last check Wednesday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Keira Knightley Revisits "Trauma" of Being Accused of Having an Eating Disorder
"I'll suddenly have a very bodily memory of it because, ultimately, it's public shaming."
Marie Claire
Marie Claire
Keira Knightley recalls ‘public shaming’ she felt amid claims she had an eating disorder
‘It’s obviously part of my psyche, given how young I was,’ she recalls about the eating disorder claims
The Independent UK
The Independent UK
The Simpsons: Hit & Run dev says they could've made 3 sequels without paying a penny for the license: "Some crazy person at the publisher - we never found out who - said no"
"We never imagined it would still be bringing some people happiness 20 years later!"
GamesRadar
GamesRadar
Wrestler, film star – and future president? Why we should all take Dwayne ‘The Rock’ Johnson seriously
The WWE icon, already one of Hollywood’s highest-paid film stars, has shown himself to be ‘focus group-proof’
The Guardian - UK
The Guardian - UK
Eating this fruit before bed can help you sleep better – but expert opinions are divided
TikTok strikes again with its avocado sleep hack – but does it actually work?
T3
T3
Cher was ‘shocked’ to discover her legal name after birth certificate mix-up
Pop icon had gone for years without knowing what was written on her birth certificate
The Independent UK
The Independent UK
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
Download on the AppStore Get it on Google Play